Related articles

personalized mRNA cancer vaccine

Moderna's individualized mRNA therapeutic vaccine against cancer, reported to reduce recurrence or death risk by 42% in advanced melanoma.

• Cancer Vaccines Advance: Moderna's Personalized mRNA Shows Promise at ESMO Congress in Madrid